In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...